SCHEMBL14412273

SCHEMBL14412273

CCCNC(=O)N1CCC(Nc2nc(NCc3ccccc3Sc3ccccc3CO)nc3ccccc23)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 9/20 0.44
▸ KDM1A O60341 3/20 0.44
▸ WHR1 P49842 1/20 0.42
▸ DNMT3A Q9Y6K1 1/20 0.41
▸ RCOR1 Q9UKL0 2/20 0.41
▸ APP P05067 3/20 0.39
▸ BCHE P06276 3/20 0.39
▸ ACHE P22303 3/20 0.39
▸ HDAC3 O15379 5/20 0.38
▸ HDAC4 P56524 5/20 0.38
▸ HDAC1 Q13547 5/20 0.38
▸ HDAC7 Q8WUI4 5/20 0.38
▸ HDAC2 Q92769 5/20 0.38
▸ HDAC10 Q969S8 5/20 0.38
▸ HDAC11 Q96DB2 5/20 0.38
▸ HDAC8 Q9BY41 5/20 0.38
▸ HDAC6 Q9UBN7 5/20 0.38
▸ HDAC9 Q9UKV0 5/20 0.38
▸ HDAC5 Q9UQL6 5/20 0.38
▸ EHMT1 Q9H9B1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256734 0.90 EHMT2 (0.47) EHMT2KDM1AWHR1DNMT3ARCOR1
SCHEMBL14256736 0.84 DNMT3A (0.53) EHMT2KDM1AWHR1DNMT3ARCOR1
SCHEMBL14266659 0.84 EHMT2 (0.42) EHMT2KDM1AWHR1DNMT3ARCOR1
SCHEMBL14256741 0.82 WHR1 (0.45) EHMT2KDM1AWHR1DNMT3AAPP
SCHEMBL14256444 0.81 MERTK (0.53) WHR1APPBCHEACHEMERTK
SCHEMBL14412253 0.81 PDE5A (0.45) EHMT2KDM1AWHR1DNMT3AAPP
SCHEMBL14256699 0.81 MERTK (0.52) APPBCHEACHEMERTKCXCR4
SCHEMBL14256733 0.81 CCR8 (0.38) JUNMAPK8MAPK9MAPK10CDK2
SCHEMBL14412248 0.80 APP (0.45) EHMT2KDM1AWHR1APPBCHE
SCHEMBL14412272 0.79 CXCR4 (0.52) WHR1APPBCHEACHEMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF EHMT2 1276/4885KDM1A 3012/4885WHR1 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback